Plain English Summary
This bill directs the North Carolina Institute of Medicine to conduct a comprehensive study on the advantages and disadvantages of legalizing medical aid in dying (MAID) in North Carolina, with findings due by April 1, 2027. The study will examine how MAID operates in the 11 U.S. jurisdictions where it is currently legal, including applicant processes, safeguards, patient demographics, and impacts on families and healthcare systems. The bill appropriates $150,000 for the study and requires at least one public hearing for community input.
Arguments in Favor
Supporters argue that this study will provide North Carolina with evidence-based information to make an informed policy decision about end-of-life options for terminally ill patients. They point to data from existing MAID states showing low utilization rates (under 0.75%), no documented cases of abuse or coercion in 50 years combined, and note that many applicants find comfort in having the option even if they don't use it. Proponents believe this research will help ensure any potential future legislation includes appropriate safeguards to protect vulnerable populations.
Arguments Against
Opponents worry that commissioning this study signals intent to eventually legalize MAID and may reflect a predetermined outcome rather than neutral inquiry. They raise concerns about vulnerable populations—including people with disabilities, the elderly, or economically disadvantaged individuals—potentially feeling pressured to choose death rather than burden families or access expensive care. Critics also emphasize religious and moral objections to MAID and question whether studying legalization in other states adequately addresses North Carolina's unique cultural, religious, and healthcare context.
AI-generated analysis based on bill text. Always verify with official sources at ncleg.gov. This is not legal or political advice.
Sponsors
Primary Sponsor
Representative · District 77
Primary Sponsor
Representative · District 115
Primary Sponsor
Representative · District 75
Primary Sponsor
Representative · District 61
Cosponsors (16)
Representative · District 18
Representative · District 100
Representative · District 48
Representative · District 30
Representative · District 102
Representative · District 8
Representative · District 72
Representative · District 49
Representative · District 50
Representative · District 56
Representative · District 45
Representative · District 76
Representative · District 88
Representative · District 11
Representative · District 116
Representative · District 103